| APO | Apolipoprotein |
| AQP2 | Aquaporin-2 |
| BCAAs | Branched chain amino acids |
| BCG | Bacillus Calmette Guérin |
| BLCA | Bladder carcinoma |
| BTA | Bladder tumor antigen |
| CCL18 | C-C motif chemokine 18 |
| CDK1 | Cycline-dependent kinase 1 |
| CXCR2 | Chemokine receptor 2 |
| CYFRA | Cytokeratin 19 fragment |
| DNA | Deoxyribonucleic acid |
| EDIL3 | EGF-like repeat and discoindin I-like domain-containing protein 3 |
| EGFR | Epidermal growth factor receptor |
| ELISA | Enzyme-linked immunosorbent assay |
| EPS8L | Epidermal growth factor receptor kinase substrate 8-like protein |
| EVs | Extracellular vesicles |
| FDA | Food and Drug Administration |
| FGFR3 | Fibroblast growth factor receptor |
| FISH | Fluorescent in situ hybridization |
| H2B1K | Histone cluster 1 H2B family member K |
| HOTAIR | HOX transcript antisense RNA |
| HOXA13 | Homeobox A13 |
| HOX-AS-2 | HOXA cluster antisense RNA 2 |
| IGFBP5 | Insulin-like growth factor-binding protein 5 |
| ISEV | International Society for Extracellular Vesicles |
| LC | Liquid chromatography |
| MALAT-1 | Metastasis-associated lung adenocarcinoma transcript 1 |
| MALDI | Matrix-assisted laser desorption/ionization |
| MDK | Midkine |
| MS | Mass spectrometry |
| MVBs | Multivesicular bodies |
| (N)MIBC | (Non-)muscle invasive bladder cancer |
| NMPs | Nuclear matrix proteins |
| PAI-1 | Plasminogen activator inhibitor 1 |
| PON2 | Paraoxonase-2 |
| ProEGF | Epidermal growth factor |
| RNA | Ribonucleic acid |
| SAA4 | Serum amyloid A4 |
| SNPs | Single nucleotide polymorphisms |
| TACSTD2 | Tumor-associated calcium-signal transducer 2 |
| Tregs | Regulatory T cells |
| UBC | Urinary bladder cancer antigen |
| UC | Ultracentrifugation |